AbbVie, Inc. (ABBV)
264.49
-0.47
(-0.18%)
USD |
NYSE |
Aug 24, 16:00
264.58
+0.09
(+0.03%)
After-Hours: 20:00
AbbVie Total Assets (Quarterly) : 135.12B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 135.12B |
| March 31, 2026 | 136.46B |
| December 31, 2025 | 133.96B |
| September 30, 2025 | 133.90B |
| June 30, 2025 | 137.18B |
| March 31, 2025 | 136.16B |
| December 31, 2024 | 135.16B |
| September 30, 2024 | 143.42B |
| June 30, 2024 | 141.94B |
| March 31, 2024 | 148.87B |
| December 31, 2023 | 134.71B |
| September 30, 2023 | 136.22B |
| June 30, 2023 | 135.37B |
| March 31, 2023 | 134.54B |
| December 31, 2022 | 138.80B |
| September 30, 2022 | 141.32B |
| June 30, 2022 | 143.19B |
| March 31, 2022 | 143.21B |
| December 31, 2021 | 146.53B |
| September 30, 2021 | 148.86B |
| June 30, 2021 | 147.97B |
| March 31, 2021 | 150.50B |
| December 31, 2020 | 150.56B |
| September 30, 2020 | 149.62B |
| June 30, 2020 | 149.53B |
| Date | Value |
|---|---|
| March 31, 2020 | 91.20B |
| December 31, 2019 | 89.12B |
| September 30, 2019 | 59.44B |
| June 30, 2019 | 57.14B |
| March 31, 2019 | 56.77B |
| December 31, 2018 | 59.35B |
| September 30, 2018 | 66.16B |
| June 30, 2018 | 61.64B |
| March 31, 2018 | 69.34B |
| December 31, 2017 | 70.79B |
| September 30, 2017 | 68.84B |
| June 30, 2017 | 66.99B |
| March 31, 2017 | 65.66B |
| December 31, 2016 | 66.10B |
| September 30, 2016 | 66.63B |
| June 30, 2016 | 67.21B |
| March 31, 2016 | 53.72B |
| December 31, 2015 | 53.05B |
| September 30, 2015 | 54.83B |
| June 30, 2015 | 53.86B |
| March 31, 2015 | 26.70B |
| December 31, 2014 | 27.55B |
| September 30, 2014 | 28.45B |
| June 30, 2014 | 29.04B |
| March 31, 2014 | 28.66B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 32.09B |
| Gilead Sciences, Inc. | 49.36B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| Amgen, Inc. | 95.64B |
| REGENXBIO, Inc. | 386.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 141.00B |
| Shareholders Equity (Quarterly) | -5.935B |
| Debt to Equity Ratio | -11.93 |
| Current Ratio | 0.8085 |
| Net Debt Paydown Yield | -0.04% |